Viewing Study NCT06310304


Ignite Creation Date: 2025-12-24 @ 7:52 PM
Ignite Modification Date: 2025-12-29 @ 10:57 PM
Study NCT ID: NCT06310304
Status: COMPLETED
Last Update Posted: 2024-06-05
First Post: 2024-03-07
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Study to Evaluate the Relative Bioavailability of Ruxolitinib Extended Release (XR) Tablets Compared With Ruxolitinib Immediate Release (IR) Tablets Administered Orally in Healthy Participants.
Sponsor: Incyte Corporation
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module